The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients With T2DM Complicated With MAFLD
Clinical trial NCT07289750 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07289750
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2027-08-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.